Cambridge University Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Therapeutics in Active Prostate Cancer Surveillance (TAPS02)
Condition: Prostate Cancer Interventions: Drug: Apalutamide Oral Tablet [Erleada]; Drug: Placebo Sponsors: Cambridge University Hospitals NHS Foundation Trust; University of Cambridge; Janssen-Cilag Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 13, 2022 Category: Research Source Type: clinical trials
Biologics in Refractory Vasculitis
Conditions: Giant Cell Arteritis; Takayasu Arteritis; Cogan Syndrome; Relapsing Polychondritis; Cryoglobulinemic Vasculitis; IgA Vasculitis; Polyarteritis Nodosa; Cutaneous Polyarteritis Nodosa; Primary Angiitis of Central Nervous System Interventions: Biological: Rituximab; Biological: Infliximab; Biological: Tocilizumab Sponsor: Cambridge University Hospitals NHS Foundation Trust Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2021 Category: Research Source Type: clinical trials
